Pain in Multiple Sclerosis

David B. Clifford; John L. Trotter

doi:10.1001/archneur.1984.04050230052017

Pain in Multiple Sclerosis

David B. Clifford, John L. Trotter

Research output: Contribution to journal › Article › peer-review

165 Scopus citations

Abstract

We reviewed 317 patients with multiple sclerosis (MS) and found that the incidence of clinically significant pain, excluding headache and paresthesia, was 28.8%. Successful treatment requires recognition of the pathophysiology of the pain syndromes encountered in MS. Antidepressant drugs have been of particular value in the treatment of chronic pain in these patients.

Original language	English
Pages (from-to)	1270-1272
Number of pages	3
Journal	Archives of neurology
Volume	41
Issue number	12
DOIs	https://doi.org/10.1001/archneur.1984.04050230052017
State	Published - Dec 1984

Access to Document

10.1001/archneur.1984.04050230052017

Cite this

@article{40d8d6fc364b44c9b6068f44ffd0c41b,

title = "Pain in Multiple Sclerosis",

abstract = "We reviewed 317 patients with multiple sclerosis (MS) and found that the incidence of clinically significant pain, excluding headache and paresthesia, was 28.8%. Successful treatment requires recognition of the pathophysiology of the pain syndromes encountered in MS. Antidepressant drugs have been of particular value in the treatment of chronic pain in these patients.",

author = "Clifford, {David B.} and Trotter, {John L.}",

year = "1984",

month = dec,

doi = "10.1001/archneur.1984.04050230052017",

language = "English",

volume = "41",

pages = "1270--1272",

journal = "Archives of neurology",

issn = "0003-9942",

number = "12",

}

TY - JOUR

T1 - Pain in Multiple Sclerosis

AU - Clifford, David B.

AU - Trotter, John L.

PY - 1984/12

Y1 - 1984/12

N2 - We reviewed 317 patients with multiple sclerosis (MS) and found that the incidence of clinically significant pain, excluding headache and paresthesia, was 28.8%. Successful treatment requires recognition of the pathophysiology of the pain syndromes encountered in MS. Antidepressant drugs have been of particular value in the treatment of chronic pain in these patients.

AB - We reviewed 317 patients with multiple sclerosis (MS) and found that the incidence of clinically significant pain, excluding headache and paresthesia, was 28.8%. Successful treatment requires recognition of the pathophysiology of the pain syndromes encountered in MS. Antidepressant drugs have been of particular value in the treatment of chronic pain in these patients.

UR - http://www.scopus.com/inward/record.url?scp=0021744667&partnerID=8YFLogxK

U2 - 10.1001/archneur.1984.04050230052017

DO - 10.1001/archneur.1984.04050230052017

M3 - Article

C2 - 6208884

AN - SCOPUS:0021744667

SN - 0003-9942

VL - 41

SP - 1270

EP - 1272

JO - Archives of neurology

JF - Archives of neurology

IS - 12

ER -

Pain in Multiple Sclerosis

Abstract

Access to Document

Other files and links

Fingerprint

Cite this